AveXis marks opening of Longmont plant

LONGMONT — AveXis Inc. marked the completion of retrofitting its 692,000-square-foot drug-manufacturing campus in Longmont Tuesday morning, capping off a year of regulatory victories and intense criticism within the health-care industry.

Before an assembled crowd of employees and public officials, AveXis president Dave Lennon said the company views the Longmont plant as the future for producing its flagship drug Zolgensma and gene therapies for other conditions in the company’s pipeline.
“Longmont will be on the leading edge of…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!